JAN 23, 2019 10:17 AM PST

Impact of Ankylosing Spondylitis on Quality of Life

WRITTEN BY: Dena Aruta

Ankylosing spondylitis (AS) is a chronic inflammatory disease that most often affects the sacroiliac (SI) joints and axial skeleton (see figure above). However, it is also a multisystemic disorder that can cause enthesitis (insertion site of tendons and ligaments into bone), peripheral arthritis, and multi-organ involvement.  Although AS has been called rheumatoid spondylitis, it's not related to rheumatoid arthritis (RA) or other rheumatic disorders; it also has a better prognosis than RA. Chronic inflammation causes changes including ossification of the annulus fibrosus (the tough exterior of the intervertebral disc) and fusion of the spine resulting in immobility and reduced physical function. AS first presents with dull pain and stiffness in the lower back in approximately 75% of patients and is accompanied by severe fatigue in 65%.


Most studies of AS have analyzed measures of disease activity and functional disabilities, but few are designed to assess the quality of life of AS patients related to their disease characteristics. The objectives of the study performed by Law et al. were: the utilization of the Medical Outcome Survey Short Form-36 (SF-36) to measure the health-related quality of life (HRQoL) of AS patients compared to controls, and the measurement of the HRQoL based on age, the correlations between spinal x-rays and SF-36 scores, mobility, physical function, demographic data, and disease activity. They defined the concept of HRQoL as "not only a person’s physical well-being, but also a person’s mental health and physical ability, both as an individual and as a participating member of the community." 

Other questionnaires used were the BASDAI (estimates disease activity) and BASFI (estimates functional limitations). The Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP), which calculates the disease activity, and the visual analog scale for global fatigue were also administered. 

Participants in this study were recruited from three sites in Western Sweden. Inclusion criteria were a diagnosis of AS by the New York criteria and adults over the age of 18. Patients were excluded if they did not understand the Swedish language or if dementia or pregnancy were present. They invited 361 participants to take part in the study, and a total of 210 patients were included. 


Analysis of the data showed that patients with AS had lower scores for HRQoL than the controls and the physical components of the disease were more limiting than the mental components in both sexes. The authors stated that, for the first time, this study "identified determinants of worse HRQoL separately in men and women with AS and we found that the factors associated with HRQoL differed in part between the sexes." They also found that the mental component scores were stable for all age groups, but the physical components score was significantly worse in patients over 61 years of age compared to those less than 40 years of age. Reducing factors involved in the ASDAS-CRP and fatigue may help to improve these patients' HRQoL. 

The researchers plan to monitor this cohort of patients for five years in a future study.

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
OCT 26, 2020
Cancer
Investigating the Receptor Protein FPR1 in Brain Cancer
OCT 26, 2020
Investigating the Receptor Protein FPR1 in Brain Cancer
Amongst the more common targets for cancer therapies are cell surface receptors. These receptors are proteins – us ...
OCT 25, 2020
Health & Medicine
Over 4 in 10 People With MS Have Used Cannabis in the Last Year
OCT 25, 2020
Over 4 in 10 People With MS Have Used Cannabis in the Last Year
University of Michigan researchers have found that Americans with Multiple sclerosis (MS) are twice as likely as the gen ...
OCT 29, 2020
Cannabis Sciences
Hemp 10 Years from Now
OCT 29, 2020
Hemp 10 Years from Now
The hemp industry has experienced major growth in recent years, largely due to legalization in many US states. Today, th ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
NOV 19, 2020
Health & Medicine
Two Studies Raise Cannabis Heart Concerns
NOV 19, 2020
Two Studies Raise Cannabis Heart Concerns
Cannabis was under discussion at the American Heart Association’s Scientific Sessions 2020 (held November 13&ndash ...
NOV 20, 2020
Neuroscience
The Link Between Sleep Apnea and Autoimmune Disease
NOV 20, 2020
The Link Between Sleep Apnea and Autoimmune Disease
Researchers from the University of Georgia have found more evidence for the link between obstructive sleep apnea (OSA) a ...
Loading Comments...